Alpha Cognition (NASDAQ:ACOG) Earns “Buy” Rating from HC Wainwright

Alpha Cognition (NASDAQ:ACOGGet Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report released on Friday,Benzinga reports. They currently have a $20.00 price target on the stock. HC Wainwright’s price target would indicate a potential upside of 131.21% from the company’s previous close.

Separately, Raymond James raised Alpha Cognition to a “moderate buy” rating in a report on Tuesday, March 25th.

View Our Latest Analysis on ACOG

Alpha Cognition Stock Up 27.0%

NASDAQ ACOG opened at $8.65 on Friday. Alpha Cognition has a twelve month low of $3.75 and a twelve month high of $9.68. The firm has a market cap of $138.57 million, a PE ratio of -3.38 and a beta of 2.48. The business’s 50-day simple moving average is $5.44.

Alpha Cognition (NASDAQ:ACOGGet Free Report) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.38.

Institutional Investors Weigh In On Alpha Cognition

Several large investors have recently modified their holdings of the stock. Solas Capital Management LLC bought a new stake in shares of Alpha Cognition in the 4th quarter valued at approximately $8,096,000. AWM Investment Company Inc. bought a new stake in Alpha Cognition during the 1st quarter worth approximately $5,785,000. Sphera Funds Management LTD. bought a new stake in Alpha Cognition during the 4th quarter worth approximately $3,652,000. Alyeska Investment Group L.P. bought a new stake in Alpha Cognition during the 4th quarter worth approximately $2,356,000. Finally, Altium Capital Management LLC bought a new stake in Alpha Cognition during the 4th quarter worth approximately $1,620,000.

Alpha Cognition Company Profile

(Get Free Report)

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

See Also

Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.